Insider Transactions in Q1 2025 at Neuro Pace Inc (NPCE)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 27
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,430
-1.74%
|
$17,160
$12.56 P/Share
|
Feb 27
2025
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,430
-1.12%
|
$17,160
$12.56 P/Share
|
Feb 21
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
78,334
-48.86%
|
$1,018,342
$13.72 P/Share
|
Feb 20
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,405
-7.23%
|
$47,670
$14.23 P/Share
|
Feb 20
2025
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,405
-2.6%
|
$47,670
$14.23 P/Share
|
Feb 20
2025
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,270,845
-100.0%
|
$47,437,605
$9.4 P/Share
|
Jan 30
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
200
-0.23%
|
$3,000
$15.0 P/Share
|
Jan 29
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
100
-0.11%
|
$1,500
$15.0 P/Share
|
Jan 24
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,200
-3.55%
|
$48,000
$15.01 P/Share
|
Jan 22
2025
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
265
-0.56%
|
$3,710
$14.04 P/Share
|
Jan 22
2025
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
265
-0.22%
|
$3,710
$14.04 P/Share
|